You are here

Article Text

Article menu
Download PDFPDF
Gene of the month
Gene of the month: GATA3
  1. Zekai Qiang1,
  2. Ibrahim Jubber1,
  3. Kirsty Lloyd2,
  4. Marcus Cumberbatch1,
  5. Jon Griffin1,2
  1. 1 Academic Urology Unit, The University of Sheffield, Sheffield, UK
  2. 2 Department of Histopathology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
  1. Correspondence to Dr Jon Griffin, Academic Urology Unit, The University of Sheffield, Sheffield, UK; Jonathan.griffin{at}sheffield.ac.uk

Abstract

GATA binding protein 3 (GATA3) is a zinc-finger pioneer transcription factor involved in diverse processes. GATA3 regulates gene expression through binding nucleosomal DNA and facilitating chromatin remodelling. Post-translational modifications modulate its activity. During development, GATA3 plays a key role in cell differentiation. Mutations in GATA3 are linked to breast and bladder cancer. GATA3 expression is a feature of the luminal subtype of bladder cancer and has implications for immune status and therapeutic response. It also has clinical relevance in squamous cell carcinomas and soft tissue sarcomas. This paper reviews the structure and function of GATA3, its role in cancer and its use and pitfalls as an immunohistochemical marker.

  • molecular biology
  • breast neoplasms
  • urologic neoplasms
  • pathology, molecular
  • immunohistochemistry

https://doi.org/10.1136/jcp-2023-209017

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Handling editor Murali Varma.

    • Contributors ZQ, JG: literature review; KL, IJ, JG: figures and histopathology images; all authors: manuscript design and writing/editing of critical intellectual content.

    • Funding JG is funded by an NIHR Clinical Lectureship and Cancer Research UK Translational Sample Collection Grant (CRCPSC-Nov22/100002).

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.